Menu Search
Equities

Ryman Healthcare Ltd

RH7:HAN

Ryman Healthcare Ltd

Actions
  • Price (EUR)2.72
  • Today's Change0.082 / 3.11%
  • Shares traded200.00
  • 1 Year change-11.05%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 16:25 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ryman Healthcare Limited is a New Zealand-based company. The Company develops, owns and operates integrated retirement villages, rest homes, and hospitals for older people within New Zealand and Australia. It provides a range of retirement-living options, including apartments and townhouses and assisted living in serviced apartments. Its aged-care offering includes rest homes, hospitals and dementia care. The Company's assisted living offers a range of services, including scheduled transport services and outings, village management and administration, maintaining and operating the community amenities, and gardening and ground maintenance and others. Its one, two and three-bedroom apartments and townhouses offer a neutral color palette. It also offers musical entertainment, fashion shows, arts and crafts, and regular outings. It owns and operates approximately 40 villages across New Zealand and eight in Australia.

  • Revenue in NZD (TTM)689.89m
  • Net income in NZD4.78m
  • Incorporated1987
  • Employees7.70k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.